On March 18th, the FDA published draft guidance on validating new approach methodologies (NAMs), including complex in vitro models (CIVMs).
To continue reading click here
The FDA has released draft guidance for NAMs Validation – Now what?
On March 18th, the FDA published draft guidance on validating new approach methodologies (NAMs), including complex in vitro models (CIVMs).
To continue reading click here